Macrophage migration inhibitory factor (MIF) plays a pivotal role in systemic and local inflammatory and immune responses. The aim of this study is to assess MIF gene expression in PBMCs harvested from obese individuals and to compare it with that of lean subjects to analyze any potential relationship between resting metabolic rate as well as several different parameters and MIF expression in PBMC. We also aim to assess anti-inflammatory characteristics of vitamin D 3 on MIF expression in vitro. Participants were 30 obese and 18 non-obese subjects who were assessed following an overnight fasting for RMR by means of indirect calorimetry. Body composition was measured using a Bodystat device. The PBMCs were separated from whole blood by the Ficoll-hypaque technique. The mRNA was extracted and the cDNA was synthesized. This process was followed by real-time PCR using primer pairs specific for MIF mRNA and beta actin as internal control. Our findings clearly demonstrate that there were significant differences in terms of BMI, BMR predict, fat proportion, fat mass, free fat mass, TBW, visceral fat, fasting serum glucose, TG, HDL, Hs-CRP and RMR between the two groups. Moreover, the level of MIF expression in the obese group was approximately 2.5 times higher compared to the lean group. An increased level of MIF expression in the obese group and a decreased expression of that non-obese was observed after inducing PBMCs with vitamin D3. One of the intriguing results of this study was the observed reverse correlation between MIF expression and fat mass as well as fat proportion after PBMCs were cultured in the presence of vitamin D 3 • Therefore, it could be concluded that MIF expression, which is in turn influenced by vitamin D 3 , has a role in the hyperactive immune profile and the pro-inflammatory state observed in obese individuals which is suggested to have a causal relationship with obesity.
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Obesity is a condition characterized by the development of excessive adipose tissue mass and has been proved to be associated with various metabolic disorders which seem to be rampant in both developing and developed countries (1) . There is growing evidence that obesity is associated with a chronic inflammation, although without any clinical manifestation (2) . This chronic inflammation is characterized by a change in cytokine production, elevated acute-phase reactant levels and exacerbation of inflammatory signal ing pathways (3) . Moreover, more macrophages are infiltrated into adipose tissue as the extent of obesity is increased (4) . It is therefore feasible to consider infiltrated macrophages as major sources of cytokines that commence the inflammatory state which, in turn, results in the development of insulin-resistant and other metabolic disorders (5) . The local interaction between adipocytes and tissue-resident macrophages and their influence on monocyte and T lymphocyte functions has been documented in a previous study (6) . Moreover, it has been demonstrated that obesity and weight gain can have an influence on the proinflammatory state of mononuclear cells (MNC)
Vitamin 0 receptor which regulates about 3% of the human genome is documented to be expressed in immune cells. Therefore, it could be deduced that vitamin 0 has some physiologic immunomodulatory role in the endocrine system (7) . Besides, a potential role for vitamin D 1 in the modulation and control of the interaction between adipocytes and macrophages is suggested (8) . More importantly, a crucial role for vitamin 0 3 is recently defined in the modulation of cytokines, which in turn, could influence energy balance and metabolism in adipocytes, macrophages, and skeletal muscles. Besides, it has been shown that calcitriol has influence on adipocyte apoptosis and plays a regulatory role in adipose tissue lipid depot location and expansion via enhancing production levels and release of glucocorticoids (9) . It is suggested that macrophage migration inhibitory factor (MIF) might have an influence on this pathway by altemating the role of glucocorticoids in the secretion of proinflammatory cytokines (10) .
MIF is an immunoregulatory cytokine which has proved to playa pivotal role in systemic and local inflammatory and immune responses. MIF was described for the first time as a soluble factor produced and secreted exclusively by activated T lymphocytes (II). MIF has a direct chemokine-like role by promoting cell recruitment. Different clinical trials have successfully demonstrated the role of MIF as a biomarker in the pathogenesis of different diseases with inflammatory components, such as systemic infections and sepsis, autoimmune diseases, cancer, and metabolic disorders such as type 2 diabetes and obesity (12) . It is documented that intracellular MIF have a biological role in adipogenesis procedure (13) . MIF also exerts its proinflammatory role by cytokine production and secretion and, as is known, proinflammatory cytokines have some effect on adipogenesis (14) . It has also been demonstrated that MIF has a unique characteristic among other pro inflammatory cytokines in terms of adipogenesis and obesity (I).
Accordingly, as vitamin D 3 is of paramount importance as the major modulator of cytokines with potentially important roles in energy balance and metabolism in adipocytes and macrophages, it is feasible to consider a similar role for this vitamin in PBMCs (3, 9) .
This study was designed to measure MIF gene expression as a protein with chemokine-like activity as well as a biomarker for inflammatory reaction in PBMCs in obese individuals and to compare it with that of non-obese subjects. Moreover, any potential relationship was analyzed between the resting metabolic rate and MIF expression in PBMC in the two above-mentioned groups. In addition, the in vitro anti-inflammatory characteristics of vitamin 0 3 on MIF expression in PBMCs were assessed.
MATERIALS AND METHODS

Study population
A total of 48 participants were included in the current case-control study, 30 (62.5%) of whom with body mass index (8Ml) equal or more than 30 kg/m-and 18 (37.5%) with BMllower than 30 kg/m", The study had the approval of the local ethics committee of the Endocrinology and Metabolism Research Center of Tehran University of Medical Sciences. The subjects were selected according to our defined inclusion criteria which was: age 22-52 years, absence of any acute or chronic inflammatory disease, no medical history of hypertension, no alcohol or drug abuse, and not being pregnant. Exclusion criteria were: history of any condition affecting inflammatory markers such as known cardiovascular diseases, thyroid diseases, malignancies, current smoking, diabetes mellitus, sustained hypertension, heart failure, acute or chronic infections, and hepatic or renal diseases. It is worthy of note that there was no significant difference in terms of gender and age between cases and the control group.
Biochemical and hormone assay
The peripheral blood samples were obtained following an overnight 10-12 h fasting. Serum was centrifuged, aliquoted and stored at a temperature of -80 "c. All samples were analyzed by means of a single assay. All measurements were performed at the EMRC laboratory of Shariatei Hospital. The GOD/PAP method was used for measurement of fasting serum glucose, triglyceride (TG) levels were calculated by GPO-PAP method, total cholesterol levels were measured by Enzymatic Endpoint method, and direct high-density lipoprotein-cholesterol (HDL) was measured using enzymatic clearance assay. All measurements were carried out using Randox Laboratories kit (Hitachi 902). Serum Hyper sensitivity C-reactive protein (hsCRP), a well-known marker of inflammation, was measured by means of immunoturbidimetric assay (High sensitivity assay, by Hitachi 902). Vitamin D 3 was obtained from Sigma (St. Louis, MO, USA).
REE measurements
Measurements were performed on all subjects by professional nutritionists using a standard protocol. Body composition was precisely examined and reported by Bodystat 1500 Medical equipment before resting energy expenditure (REE) measurement and the subjects were without shoes. This is explained in detail below. Height was measured using Seca 200 Girth Measuring Tape and we followed the established protocol (without shoes; heels together; subject's heels, buttocks, shoulders, and head touching the vertical wall surface; and with line of sight aligned horizontally). REE was measured using FitMate calorimetry (Cosmed Company, Rome, Italy). FitMate is a brand new, small (20 x 24 em) metabolic analyzer with a mask to cover the nose and mouth which is designed to measure oxygen consumption and energy expenditure during rest and exercise. Furthermore, it uses a turbine flowmeter to measure ventilation and a galvanic fuel cell oxygen sensor for analyzing the proportion of oxygen in expiration gases. Moreover, it uses a patent pending novel sampling that allows the FitMate to retain the performance of a metabolic cart in a standard mixing chamber. Resting metabolic rate (RMR) is calculated using information such as: oxygen consumption, a fixed respiratory quotient (RQ) of 0.85, and estimated quantity of urinary nitrogen using a modified Weir equation. Weir equation: REE = [0 2 consumed (liter) x 3.941 + produced co-(liter) x 1.11]
x 1440 min/dRMR was measured by indirect calorimetry following an overnight period of 10-12 hour fasting.
The subjects were required to fast and not to be physical1y activate for 12 h before the test and to abstain from smoking ::::: I h before testing although the ideal interval was 12 h to make sure that the body is in a resting and post-absorptive state. Patients were instructed to rest in a supine position on a mattress for 15 min and then measurement was carried out for a period of 7 min. However, the first 2 minutes were not considered and only the last 5 minutes were used to calculate REE.
Complete body composition analysis
Bodystat 1500 Medical equipment was utilized to study body composition. The machine has four main cable leads with crocodile/alligator clips. Clips were fixed to the exposed metallic tabs on the electrodes. Self-adhesive disposable electrodes were attached to the right hand and right foot. The body composition analyzer's mechanism of action is transmitting a safe battery-generated electronic signal throughout the body and measuring the impedance at a fixed frequency of 50 kl-lz. Three keypads were used to input certain data such as the subject's gender, age, height, weight, and activity level. After the test was performed, the patient's complete body composition analysis was displayed on a screen within three seconds. The body composition consisted of body fat proportion as percent and fat weight, lean mass proportion and body lean mass, total body water proportion and total body water weight in addition to normal levels.
PBMC preparation
Peripheral blood mononuclear cells (PBMCs) were isolated from blood (12 ml, heparin tube) collected by venous puncture. PBMCs were isolated from peripheral blood using the Ficoll density method. To summarize, blood was diluted to a 1/1 solution with RPMI 1640 supplemented with Glutamax-l, 25 mM HEPES (Cambrex Bio Science, Verviers, Belgium) and appropriate antibiotics (I OOU/ml penicillin and 100mg/ml streptomycin). Twenty-four ml of the solution was laid on top of 15 ml of a high density solution (Lymphoprep'TM, Axis-Shield PoCAS, Oslo, Norway) and centrifuged at a speed of 1500 rpm for 20 min. The middle layer, which consisted of peripheral blood mononuclear cells, was separated and washed twice. PBMCs were cultured in RPMI 1640 supplemented with Glutamax-I, 25 mM HEPES (Cambrex Bio Science, Verviers, Belgium) and antibiotics (I OOU/ml penicillin and 100mg/ml streptomycin) plus 15% FCS for 24 hours. In parallel experiments, vitamin D, (10-7 M) (Sigma-Aldrich, St. Louis, MO) were added to some cultures either at the beginning or at the end of the cultivating process.
RNA extraction and Quantitative real-time RT-PCR
At every single turn, 10 6 cells were harvested and mRNA extraction was performed using the High Pure RNA isolation kit (Roche Diagnostics). MIF and beta actin genes were quantified by means of quantitative realtime reverse transcriptase (RT)-PCR as described in detail elsewhere. Briefly, 50 ng mRNA was reverse transcribed using Revert Aid First Strand cDNA Synthesis Kit (Fermentase, EU). For subsequent RT-PCR amplification, a maximum of 2 III of each cDNA sample was used per 20 III PCR-mix. PCR reactions were performed either in triplicate wells, or in an ABI Step One real time System (Applied Biosystems, Foster City, CA). Reagents needed for the PCR reaction were purchased from Applied Biosystems and each sample was run in triplicate in a volume of 20 III for up to 40 cycles using standard realtime cycling conditions. The Ct-values were normalized to a relative standard curve run at the same plate as the samples. The relative quantification of target gene expression was normalized to a housekeeping gene (beta actin) expression for each sample. Data were reported as fold change in mRNA level compared to a control group.
Statistical analyses
Chi-square test was used for comparison of the frequency of variables between two groups. Correlation analysis was performed for quantifying MIF gene expression and various variables were measured in two groups before and after induction with vitamin D J in PBMCs. The level of significance was set at a probability of :S0.05 for all tests.
RESULTS
Study population characteristics
A total of 48 participants (93% female, 7% male) were included in the current case-control study. The means for ages, height and weight ofparticipants were 35.03±9.15 years, 159.75±6.15 cmand 81.04±11.08 kg, respectively. In 30 (62.5%) participants body mass index (8MI) were equal or more than 30 kg/ m-and in 18 (37.5%) individuals BMI was lower than 30 kg/rn-. Obese subjects and controls were not suffering from any infectious condition at the time of sampling. Study population characteristics, anthropometric and laboratory measurements in each group are summarized in Table I . There were no statistically significant differences in terms of sex distribution and means of age between the study groups. As shown in Table I , the study and the control group showed significant differences in terms of 8\11, basal metabolic rate prediction (8MR predict), fat percent, fat mass, free fat mass, total body water (TBW), visceral fat, fasting serum glucose, TG, HDL, Hs-CRP and RMR. There were no significant differences however, in terms of age, total cholesterol and resting metabolic rate/lean body mass (RMR/LBM) between the two groups.
MIF gene expression profiles in PBMC of the two groups
The change in M1F gene expression level profiles in PBMCs obtained from the two groups was evaluated before and after treatment with vitamin Dr The M1F gene was 2.5 times more highly expressed in the obese group compared to the control group. However, a significantly positive correlation between the levels ofMIF gene expression and age, HDL levels, and fasting serum glucose was detected in the non-obese group. With regard to the obese group, a positive correlation between levels of fasting serum glucose, TG, RMR/kg and RMR/LBM and levels ofMIF expression was observed as shown in Table II .
Evaluation of MIF gene expression levels after treatment with vitamin 03
Evaluation of MIF gene expression levels after treatment with vitamin OJ demonstrated different levels of MIF expression in two groups as shown in Fig. I . An increased level of M1F expression in the non-obese group and a decreased level of its expression in the obese group were detected after inducing PBMCs with vitamin 0 3 , Correlation analysis after induction demonstrated a significantly positive correlation between levels ofM1F expression and age, visceral fat, fasting serum glucose and HDL in the non-obese group. This analysis in the obese group demonstrated a significant correlation between 8MR predict, FFM, TBW,TG, total cholesterol and a negative correlation with age, fat percent, fat mass and RMR/LBM with the MIF relative expression (Table III) .
DISCUSSION
Similar to our results, the findings of a recent study demonstrated that Hs-CRP is a major biochemical surrogate marker for increased adipose tissue mass (15) . Our study is in congruence with the results of a study which demonstrated that M1Fplays a key role in accumulationoftriglycerides in 3T3-Ll adipocytes (16) . Also Dandona et al, consistent with our results, reported that plasma MIF concentrations and MIF mRNA expression in MNCs were elevated in obese individuals (17) . This finding can be explained, in part, by the proinflammatory state that is documented to exist in obesity. MIF is an innate cytokine with a role in pathogenesis of various inflammatory and autoimmune disorders. The proinflammatory characteristic of this cytokine is also demonstrated by its impact on increasing levels of different proinflammatory mediators such as C-reactive protein (CRP) (18) . Furthermore, some documented epidemiological and clinical studies suggest that there is an important relationship between MIF and obesity, glucose metabolism disorders, and development of insulin resistance (18) . Herder and colleagues reported a strong positive association between systemic concentrations of MIF and impaired glucose tolerance (19) and it is documented that MIF inhibits insulin signal transduction (20) . Moreover, MIF is shown to decrease tyrosine phosphorylation of insulin receptor substrate-l (IRS-1) and to reduce its association with P85, thereby inhibiting insulin-induced phosphorylation of AKT, which is known to provide signals for synthesis of new glucose transporters (18) . On the other hand, MIF is proved to have a role in insulin production and release from l3-cells in pancreatic islets (21). It is also documented that MIF functions as an enzyme with the role of weakening sulfhydryl linkages and breaking existing ones (22) .
The results indicate that vitamin D has a role in frustration ofMIF gene expression, and consequently, affects adiposity axis and the underlying mechanism for its suggested role in its anti-obesity function. Larsen et al. studied a potential endogenous immune regulatory role for vitamin D, in various cells (23) . The result was shown that vitamin D, inhibited some cytokine production and mRNA expression in keratinocytes, fibroblasts and PBMC. Also Giulietti et al. (24) designed a study to investigate the role of monocytes in sub-clinical inflammatory state and analyzed the role of vitamin D 3 , the active form of Vitamin D, as an anti-inflammatory agent. For this purpose, monocytes from type 2 diabetic patients were compared to monocytes from healthy controls and type 1 diabetic patient. The results of that study demonstrated that vitamin D 3 was able to downregulate the expression ofTNF-a, IL-6, IL-l , and IL-8, thus confirming its immunomodulatory roles. In consistence with the conclusion of the Giulietti et al. study (24) which indicated that vitamin D 3 was able to modulate inflammation in monocytes harvested from type 2 diabetic patients, the results of the present study demonstrate that PBMCs from obese subjects showed pro-inflammatory characteristics and vitamin D 3 was able to regulate inflammation in these cells.
Obesity-associated vitamin 0 deficiency is suggested to be due to the decreased bioavailability of vitamin D 3 from cutaneous and dietary sources as well as its being deposited in the body adipose tissue (25) . The effect of vitamin D 3 in down-regulating the pro-inflammatory profile in obese subjects could explain the link between Vitamin 0 deficiency and increased VDR density in PBMCs. Regarding the pattern of MIF gene expression in the obese group, it may be explained by the fact that vitamin D 3 also stimulates tumor necrosis factor in macrophages. It must be noted, however, that all those effects can be blocked by either a calcium-channel antagonist or a mitochondrial uncoupling agent (26) . Uncoupling protein-I levels, a mediator ofdissociation ofcellular respiration from energy production, was found to be greater than 25-fold higher in white adipose tissue of VDR knocked out mice. Furthermore, in another animal study, VDR knocked-out mice were shown to be resistant to high-fat diet-induced weight gain (27) . Moreover, it appears that in obese individuals with lower concentrations of vitamin D and higher VDR density, protein-l levels are lower than the normal weight population.
Oshima et al. suggested a potential underlying mechanism for the significant differences in response to vitamin D induction in PBMCs in terms of MIF gene expression levels (28) . They suggested that a change in NF-KB activation might have a regulatory role in MIF gene expression. In their study, levels of mRNA of NF-KB related proinflammatory genes, tumor necrosis factor-a (TNF-o:), and MIF changed significantly during weight gain or weight loss periods (3) . Besides, there is evidence that vitamin D induces Ikappa B alpha, an NF-kappaB inhibitor, in cells from certain different lineages (29) . It could therefore be deduced that different levels of NF-KB in obese and lean subjects played a role in our study as the underlying mechanism.
This study defines a novel role for vitamin D 3 in the regulation of the levels of MIF expression. It seems that the effect of vitamin D as an antiinflammatory or pro-inflammatory factor in PBMCs depends on each individual cells' characteristics. Moreover, we observed an altered immune response in obese subjects in response to exposure to vitamin D. Thus, we conclude that this change in immune response could potentially have a causal relationship with obesity. We believe that further research is warranted to further elucidate the role of vitamin D in systemic and local inflammatory state in obesity.
